Related Experiment Video
Updated: Feb 26, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Inflammation Is Associated With Platelet Coagulation Function Rather Than Enzymatic Coagulation Function in Patients
Xiao Wang1, Aimin Dang1, Naqiang Lv1
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College.
Takayasu arteritis (TA) involves altered platelet function, not enzymatic coagulation, during inflammation. Enhanced antiplatelet therapy may improve patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Immunology
Background:
- Takayasu arteritis (TA) is a large-vessel vasculitis with incompletely understood coagulation and fibrinolysis changes.
- The relationship between inflammation and these hemostatic processes in TA patients requires further elucidation.
Purpose of the Study:
- To investigate coagulation and fibrinolysis alterations in Takayasu arteritis patients using thrombelastography (TEG).
- To correlate these hemostatic changes with disease activity and inflammation markers.
Main Methods:
- Retrospective analysis of 127 TA patients and 55 healthy controls.
- Assessed routine hematological parameters, traditional coagulation assays, and TEG parameters.
- Grouped TA patients based on disease activity.
Main Results:
- TA patients, particularly those with active disease, exhibited shorter K time, larger alpha angle, and elevated MA, MA(A), G, and TPI.
- No significant differences in R time, EPL, LY30, and CL30 were observed between TA patients and controls, or across different disease activity groups.
- Erythrocyte Sedimentation Rate (ESR) correlated with platelet count (PLT) and several TEG parameters, including K time, alpha angle, MA, MA(A), G, and TPI.
Conclusions:
- Inflammation in Takayasu arteritis is linked to enhanced platelet coagulation function, not enzymatic coagulation.
- Findings suggest a potential benefit of antiplatelet therapy for improving the prognosis of TA patients.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Inflammation
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

